Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Leukemia, Myeloid, Acute 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Myelodysplastic Syndromes 16Lymphoma, Non-Hodgkin 10Myeloproliferative Disorders 9Multiple Myeloma 9Lymphoma, Follicular 9Leukemia, Myelomonocytic, Chronic 9Leukemia, Lymphocytic, Chronic, B-Cell 9Hodgkin Disease 9Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Primary Myelofibrosis 7Lymphoma, Mantle-Cell 7Leukemia, Biphenotypic, Acute 7Leukemia 7Anemia, Refractory, with Excess of Blasts 7Lymphoma, T-Cell 6Lymphoma 6Burkitt Lymphoma 6Lymphoma, Large B-Cell, Diffuse 5Anemia, Aplastic 5Waldenstrom Macroglobulinemia 4Polycythemia Vera 4Leukemia, Myeloid 4Leukemia, Lymphoid 4Hematologic Neoplasms 4Congenital Abnormalities 4Recurrence 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precancerous Conditions 3

Interventions

fludarabine 2Cyclophosphamide 2thymoglobulin 1prednylidene 1ofatumumab 1deltacortene 1daratumumab 1carmustine, poliferprosan 20 drug combination 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Etoposide 1Cytarabine 1Carmustine 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Autoimmune Diseases of the Nervous System × Peripheral Blood Stem Cell Transplantation × 1 year × Clear all
NCT00716066 2026-02-27

Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases

Fred Hutchinson Cancer Center

Phase 2 Active not recruiting
53 enrolled
CNS

Rasmussen subacute encephalitis, Autoimmune Diseases, Myasthenia Gravis, Neuromyelitis Optica, Lambert-Eaton Myasthenic Syndrome, Stiff-Person Syndrome, Autoimmune Diseases of the Nervous System, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Vasculitis, Central Nervous System, Opsoclonus-Myoclonus Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡